Eosinophilic Granulomatosis With Polyangiitis (EGPA) research hub

A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases

This study is looking into a medicine called benralizumab for children aged 6 to 17 with rare blood conditions called EGPA or HES. We want to see if it's safe, how well it works, and how the body handles it over time.